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INTRODUCTION. 
The present paper deals with a  strain of Pneumococcus which is 
related to, but not identical with typical strains of the Type III group. 
The general interest in strains of bacteria that possess a  specific im- 
munological relationship to one of the "fixed" types (1) of any impor- 
tant pathogenic group acquires special interest in the case of pneumo- 
cocci in view of the fact that the specificity of Pneumococcus Types I, 
II and III furnishes the most clear-cut example in all bacteriology of 
the dependence of exquisite biological specificity upon the chemical 
constitution of the bacteria themselves (2). 
In order to avoid any confusion that might arise from either the 
term "subgroup" or the term "atypical," the terms "Thomas strain" 
and "anti-Thomas serum" are used throughout the present paper to 
designate the "iron-typical" strain and its antiserum. 
It is important to point out at the beginning,  that the Thomas strain is virulent, 
killing mice within 36 hours in doses of 1 X  10 -s cc. of plain broth culture.  As 
shown by Tillett (3), the type-specific agglutination of the "S" forms of Type 
III pneumococci involves an anti-S antibody in contrast to the anti-P antibody 
*  Mr. Gaspari's  cooperation  in  this  work was made possible  by a grant  from 
The  Henry Strong  Denison Medical Foundation. 
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which agglutinates the "R" or degraded forms of all types of pneumococci.  The 
characteristics which  distinguish the Thomas strain from the typical Type III 
pneumococcus  are  recognized  by S-anti-S  reactions,  and  have  nothing  to  do 
with those which  distinguish the "S" forms (S-producing)  of pneumococci from 
the avirulent, degraded or "R" forms (non-S-producing).  Although not described 
in detail, the controls included in all experiments were sufficient to eliminate any 
complications arising from failure to differentiate the anti-S reactions from anti-P 
reactions.  The high degree of virulence of the strain,  the characteristic anti-S 
character of the agglutination of the bacteria and of the precipitation of young 
broth culture filtrates by the homologous antiserum, as well as actual tests of the 
non-type-specific protein-precipitating (anti-P) capacity of the antiserum, are in 
themselves convincing evidence  that  the  Thomas strain  is  not  a  "degraded" 
form of typical Type III pneumococcus. 
The Thomas strain  exhibits no immunological relationship to Type I  or II 
pneumococci with the exception of the species-specific P-anti-P relationship which 
is common to all pneumococci: the Thomas pneumococci are not agglutinated 
by Type I  or II antiserum nor do these antisera confer passive protection; anti- 
Thomas immune serum is likewise non-reactive against Types I and II pneumo- 
cocci; similarly, absorption of Type I or II antiserum with Thomas bacteria and 
absorption of anti-Thomas serum with Type I or II bacteria have no effect upon 
the type-specific antibodies. 
EXPERIMENTAL 
Methods. 
In  this investigation,  five different methods have been used  in  testing  the 
immune sera for the presence of the antibody specifically  reactive with Type III 
pneumococci.  These methods can be arranged in the following order of delicacy: 
(1)  specific,  passive protection of mice against virulent Type III bacteria;  (2) 
agglutination of concentrated suspensions of heated Type III bacterial cells in 
salt  solution;  (3)  agglutination  of  heated  broth  culture;  (4)agglutination  of 
unheated broth culture; (5) precipitation of solutions of the Type III specific S 
substance.  The  different  procedures  simply  represent  different  methods of 
detecting the same anti-S antibody, and the positive results obtained when an 
immune serum is tested by one method, and the negative results obtained when 
the same serum is tested by another method, are due to differences  in delicacy 
of the method of test. 
The Relationship  of the  Thomas  Strain  to  Typical  Type  III Strain 
of Pneumococci as Evidenced in Tests with Potent Anti-Type Ill 
Serum and Potent Anti-Thomas Serum. 
The comparison in Table I  of the immunological properties of the 
Thomas pneumococci with  those of typical Type III pneumococci,  is SUGG~ GASPARI~  ~?LE~IING~  AND I~EILL  919 
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based upon tests made with the most potent anti-Thomas and the most 
potent anti-Type III serum which we have obtained.  While there are 
wide variations in the individual potencies of the anti-Thomas and 
anti-Type III serum obtained from different animals, it is desirable to 
base the first comparison upon the immunological properties exhibited 
in immune sera containing the complete expression of the antigenic 
properties of the two related but different kinds of pneumococci. 
As shown in Table I, the Thomas strain of pneumococci reacts with 
anti-Type III serum, although its agglutination, filtrate precipitation 
and passive protection are not as pronounced as are the corresponding 
reactions of typical Type III pneumococci in anti-Type III serum. 
Thus, in respect to the reactions in potent samples of Type III im- 
mune serum the Thomas strain appears to be related to typical Type 
III pneumococci in about the same way as Avery's (1) Subgroup IIa 
strains are related to typical Type II pneumococci. 
However, the  comparison of the  two  strains  in  the  anti-Thomas 
serum gives a more clear-cut differentiation between the Thomas and 
the typical Type III strains.  In the first place, the anti-Thomas serum 
reacts not only with the Thomas pneumococci but also with typical 
strains of Type HI pneumococci.  In the second place, the potency 
of the anti-Thomas serum against the Thomas bacteria is much greater 
than the potency of anti-Type III serum against Type III pneumococci 
themselves; the invariable protection of mice against 0.01 cc. of broth 
culture (1 million lethal doses) and the definite agglutination of broth 
cultures by 1/320 dilution of serum being of  a much higher order of 
potency than  that  obtained with  typical Type  III pneumococci in 
anti-Type HI serum whether from rabbits or hyperimmunized horses. 
This high degree of homologous potency of the ~ntiserum produced by 
immunization with the atypical strain was a  frequent occurrence in 
Avery's (1) work with the different Subgroup Type II pneumococci, 
but the reactivity of typical Type HI strains in the anti-Thomas semJrn 
is in direct contrast to the lack of any reactivity of typical Type II 
strains in any of the different Subgroup Type II antisera. SUGG~ GASPARI, ]~LEM.ING~  AND NEILL  921 
Variations  in  the  Relative  Potencies  of  Different  Type  III  Immune 
Sera in Respect to Antibodies Reactive with a Typical Type III 
Strain and Antibodies Reactive with the Thomas Strain. 
The comparison in Table  I  of the Thomas  strain with a  typical 
Type III strain was based upon their reactions in immune sera chosen 
for their potency against both the Thomas strain and typical Type III 
strains.  During the investigation, many tests have been made with 
a  number of different Type III immune sera.  The results  of these 
tests showed a wide range of differences in the relation between the 
anti-Type III and the  anti-Thomas potency in different  anti-Type 
III  sera.  The  reactivity  of  the  serum  against  typical  Type  III 
pneumococci had  no  regular  relation  to  its  reactivity  against  the 
Thomas pneumococci.  For example, one of the anti-Type III  sera 
that was most reactive against typical Type III pneumococci did not 
agglutinate the Thomas strain at all after 2 hours incubation at 37°C. 
and only occasionally agglutinated it after storage in the ice box over- 
night.  Similarly, one of the anti-Type III sera that was weakly reac- 
tive against typical Type III strains was as reactive against the Thomas 
strain as any of the sera that we tested.  This lack of any relation 
between the anti-Thomas potency and the anti-Type III potency of 
the individual sera is important if it  represents a  difference in  the 
relative proportion of two slightly different antibodies in the serum 
obtained  from  different  horses  after  immunization with  Type  III 
pneumococci. 
Variations  in  the  Relative  Potencies  of Anti-Thomas  Serum from 
Different Rabbits in Respect to Antibodies Reactive with Typical 
Type III Strains and A'~tibodies Reactive  with the 
Thomas Strain. 
During the investigation, ten different rabbits were immunized  with 
heat-killed suspensions of the Thomas pneumococci.  A summary of 
the results of the tests of the potencies of these anti-Thomas rabbit 
sera is presented in Table II. 
An analysis of Table II reveals two important facts:  (1) the  anti- 
Thomas sera obtained from ten rabbits showed no great  difference in 
their respective potencies against the homologous strain; (2) in spite 922  P~tr~ococcI.  I 
of the uniformly good anti-Thomas immunity response, the sera of the 
same  rabbits  showed  great  differences in  their  respective  potencies 
against the typical Type III strain. 
If the homologous potenc.y be dismissed as uniformly good in all of 
the anti-Thomas sera, it is possible to arrange the sera from the ten 
rabbits into three groups in respect to their potency against typical 
TABLE  II. 
Variations  in Relative  Potencies  of Anti-Thomas  Immune Serum from  Differen~ 
Rabbits in Respect to Antibodies  Reactive with Typical Type Ill 
Pneumacocci and Antibodies Reactive with the Thomes 
(Homologous)  Strain. 
Anti-Thoma~ 
sera 
~erum from 2 
rabbits 
~erum from 7 
rabbits 
~erum from 1 
rabbit 
Antibodies reactive with ty.pical Type III 
pneumocqccl 
Agglutination 
~°o~ 
~  o ~.~ 
+  +  + 
0  4-  4- 
o  o  o 
uo-- 
o-t~  °~ 
B~ o 
+ 
.~x 
+ 
+ 
0 
Antibodies reactive with Thomas 
(homologous) strain 
~  .~G 
,_~=  ..~  .~  . 
+  +  + 
+  +  + 
+  +  + 
0 = negative results in all tests with all sera; 4-  =  definitely positive results 
with 5 of the sera, but equivocal  results with 2 sera of this group; +  = definitely 
positive results in all tests with all sera. 
Type III pneumococci.  The first group  includes the sera from two 
rabbits:  these  anti-Thomas  sera  agglutinated  unheated  broth  cul- 
tures of Type III pneumococci almost as  well as the best Type III 
immune horse sera and were much more  reactive than some of the 
diagnostic sera supplied by biological houses for routine typing.  The 
second group includes the sera from seven rabbits:  they failed to ag- 
giutinate unheated cultures of Type III strains, some of them aggiu- SUGG~ GASPARI, ]FLEMING~ AND  NEILL  923 
tinated heated  cultures, most of them agglutinated concentrated sus- 
pensions of the bacterial cells and all of them passively protected mice 
against typical Type III pneumococci.  The third group includes the 
serum  from  one  rabbit  which,  although  highly  potent  against  the 
Thomas  strain,  failed  entirely to  show  any  type-specific immunity 
against typical Type III strains; the lack of protection against mini- 
mal doses, which is the most delicate criterion, being accepted as evi- 
dence of the complete lack of anti-Type III antibodies.  From the stand- 
point of the urobability of the presence of two  different anti-S  anti- 
bodies in the same antiserum, it is important to note that these marked 
variations  in  anti-Type  III  potency  occurred  in  anti-Thomas  sera 
which  showed  no  significant  differences  in  their  potency  against 
Thomas pneumococci. 
It seems unlikely that these differences in the amounts of anti-Type III anti- 
body in anti-Thomas sera containing uniformly large amounts of the anti-Thomas 
antibody, are due to differences in the antigen injected.  All of our ten rabbits 
were not immunized at the same time, and it happened that the first four rabbits 
(injected in June and July) gave better anti-Type III responses than two rabbits 
immunized later (injected in September and October).  We thought at that time 
that the poorer response  of the latter rabbits might have been due to a change 
in the antigenic properties of the Thomas strain.  In order to rule out the pos- 
sibility of the repeated mouse passage of the culture having changed the Thomas 
strain in the direction of loss of its Type III antigenic capacity, two rabbits were 
later (November and December) immunized with the mouse passage  strain and 
two other rabbits with vaccine prepared from a culture which had been in the ice 
box for 3 months without animal passage.  The sera of all four animals gave the 
usual  strong  anti-Thomas  response;  and  the  variations  in  the  anti-Type III 
response were unrelated to the mouse passage of the culture. 
Tests for  the  Presence of Type-Specific Anti-Type III Antibody  in 
A nti-Thomas Sera by Precipitation of Solutions of the 
Purified Carbohydrate S Substance Derived from 
Typical Type III Pneumococci. 
In preceding experiments, filtrates of young broth cultures of the Thomas 
strain and of typical Type III strains were employed as sources of the specific S 
substance  elaborated by  virulent  type-specific  pneumococci.  It  seemed  im- 
portant, however, to test the Thomas antisera against solutions  of the purified 
carbohydrate S substance derived from typical Type III strains (4).  A sample 
of the carbohydrate S substance furnished for this purpose by Dr. O. T. Avery 924  l~l~.r~ococci,  i 
of the Hospital of The Rockefe1|er  Institute, was tested against the anti-Thomas 
immune sera.  The tests were made by adding 0.2 cc. of serum to 0.5 cc. of three 
different dilutions of the S substance (i/I0,000,  1/50,000 and I/I00,000).  The 
immune sera from four of the animals immunized earlier in the investigation were 
no longer available at the time the purified solution was obtained. 
The results of the tests with the purified carbohydrate confirmed the 
results of the preceding tests with the filtrates of the Type III cul- 
tures,  for the sera of some of the rabbits  immunized with Thomas 
pneumococci precipitated the solutions of the highly specific and chemi- 
cally purified carbohydrate substance prepared from typical Type III 
pneumococci.  The  prozone  phenomenon  was  much  more  marked 
than in tests with anti-Type III horse serum.  The two most reactive 
anti-Thomas sera precipitated the  1/50,000  solution better than the 
i/I0,000  solution,  and gave no  definite reaction at all in  tests with 
I/1,000  solution.  This  marked  prozone  made  it  seem inadvisable 
to attempt to increase the number of positively reacting anti-Thomas 
sera by repeating the tests with higher concentrations of antigen. 
Absorption  of  Type  III  Immune  Horse Sera  with  Suspensions  of 
Typical Type III Pneumococci and with Suspensions 
of the Thomas Strain. 
Anti-Type III serum was absorbed with suspensions of typical Type 
III pneumococci and with suspensions of Thomas pneumococci.  In 
view of the factors that may influence the results of absorption tests, 
ten experiments were made with three different anti-Type III immune 
sera, under quantitatively different sets of conditions. 
The  results of these  experiments were the  same  as  those usually 
obtained in  reciprocal absorption  experiments with immunologically 
related,  but  different,  kinds  of  bacteria.  Absorption  of  the  anti- 
Type  III  serum  with  the  typical  strain  (homologous)  completely 
exhausted it  not  only of antibodies  reactive with typical  Type III 
strains but  also of those reactive with the Thomas strain.  On the 
other hand,  repeated absorption with the Thomas bacteria (heterol- 
ogous)  removed only the antibodies reactive with the Thomas strain 
and had little, if any, effect upon the potency of the serum when tested 
against the typical strain.  The failure of repeated absorption  with 
the Thomas bacteria to reduce the anti-Type III potency seems to us SUGG~ GASPARI, I~I".EN~ING,  AND NEILI,  925 
to indicate the presence of at least two different type-specific (anti-S) 
antibodies in Type III immune horse serum, only one of which can be 
removed by the Thomas strain. 
Absorption of Anti-Thomas  Immune Sera with Suspensions of Typical 
Type III Pneumococci and with Suspensions oJ the 
Thomas Strain. 
Anti-Thomas serum, potent against both typical Type III strains 
and the homologous Thomas strain, was absorbed with suspensions 
of the typical Type III bacteria and with suspensions of the Thomas 
bacteria under conditions analogous to those employed in the absorp- 
tion of anti-Type III serum.  The results of these experiments, which 
have been repeated many times with four different anti-Thomas im- 
mune sera, are summarized as follows: 
Absorption  of  anti-Thomas  serum  with  the  homologous  strain 
stripped the serum of antibodies reactive with typical Type III organ- 
isms as well as those reactive with the homologous (Thomas) organ- 
isms.  Absorption with the typical Type III strain, on the other hand, 
removed only the antibodies reactive with typical Type III organisms 
and  did not  significantly d~rnluish the  anti-Thomas  potency of the 
serum. 
Tests w#h Other Typical Strains of Type III PneumococcL 
In most of the previously described experiments, one strain  (A 66, 
Hospital of The Rockefeller Institute) was utilized as the representa- 
tive of the typical Type III group.  In order to determine if the rela- 
tions found between the Thomas strain and the representative typical 
strain would hold true for other "typical" strains of Type III pneu- 
mococci we have repeated  most of the described experiments with 
three  different  Type  III  strains  recently  isolated  from  different 
patients at the Vanderbilt University Hospital. 
The  anti-Thomas  serum  agglutinated  and  protected  against the 
recently isolated strains as well as in the previous tests with the Rocke- 
feller laboratory strain.  Similarly, the Type III immune horse sera 
were completely stripped of antibodies  (both anti-Type III and anti- 
Thomas) by absorption with the Nashville strains; and absorption of 
the anti-Thomas sera removed the anti-Type III and not  the  anti- 926  P~Et~OCOCCL  I 
Thomas  antibodies  just  as  had  absorption  with  the  previously used 
Rockefeller strain.  The repetition of the preceding  experiments with 
these different and recently isolated strains adds considerable strength 
to all of the results and makes the absorption experiments much more 
convincing. 
While the three strains (isolated in Nashville)  represent too small a 
number to argue for the immunological homogeneity of the Type III 
group, the experiments with the recently isolated strains do serve to 
rule out the possibility that the  preceding absorption results were due 
simply to our having used the same strain as that commonly used in 
the production of the Type III diagnostic serum in the different labo- 
ratories,  and  show  that  the  anti-Thomas  immune  serum  contains 
antibodies reactive with more than one strain of "typical" Type  III 
pneumococci. 
The necessity of repeating the preceding work with those additional strains 
which were known not to be the same as those utilized in the production of the 
anti-Type III serum is especiaUy evident in view of the possibility that all of the 
biological  producing laboratories may use the same strain in the production of 
anti-Type III diagnostic serum.  And, it seemed  probable to us that perhaps 
this one strain, the original source having been the Hospital of The Rockefeller 
Institute, might be the same one as that  which we have employed as the repre- 
sentative Type III strain in our preceding experiments. 
The Protection  Test as a Criterion of the "Type Purity" of Pneurnococcus 
Cultures. 
The Thomas strain has been plated out repeatedly and we are convinced that 
its serological relationship to Type III is real, and not an apparent relationship 
due to the use of a mixed culture containing a few Type III organisms  together 
with an unrelated Group IV strain.  The fact that Type III immune horse sera 
produced in four different laboratories (by immunization with presumably "pure" 
Type III organisms)  possessed  marked protective power  against the  Thomas 
strain, seems to us to be in itself convincing evidence of the "type purity" of the 
culture. 
As pointed out by Avery (1) specific protection is the ultimate criterion of type 
specificity among the pneumococci.  Since protection tests offer the most delicate 
index of the presence  of pneumococcus  type-specific  antibodies and suffice to 
detect them in antisera when test-tube methods fail, they should likewise prove 
to be the most delicate criteria of the "type purity" of pneumococcus  cultures. 
For example, agglutination with the usual type sera would probably fail to detect SUGG, GASPARI~ FLE~IING,  AND  NEILL  927 
the presence of virulent Group IV pneumococci if mixed in small amounts with a 
Type III culture, but if passive protection tests were made, the mice would be 
infected by the small numbers of virulent Group IV organisms  in spite of the 
protection conferred against the Type III bacteria themselves. 
While it seemed certain that this principle would always hold true with virulent 
cultures, we have made two different sorts of experiments in order to test it. 
First, experiments were made in which the protective power of Type III serum was 
tested against:  (a)  Type III bacteria by themselves;  (b)  mixed cultures con- 
taining Type III and Type II bacteria in proportion of  1,000 to 1;  (c) mixed 
cultures containing Type III and Type II in proportion of 10,000 to 1.  The 
results of these experiments were exactly what one would expect if the presence 
of sensitized Type III pneumococci did not affect the virulence of the heterologous 
organism.  The Type III serum protected against Type III alone,  and failed 
against mixtures of Type III bacteria with 0.1 and 0.01 per cent of the heterologous 
organisms.  All of the mice were autopsied.  It is obvious that the experiment 
was concerned only with the animals which were killed by the mixed culture and 
not by the same amount of "pure" Type III; and typing of the heart's blood 
culture from these mice indicated that the heterologous organism  was the sole 
cause of death and that the sensitized Type III bacteria had failed to survive in 
the blood stream even in mice having a septicemia due to the heterologous  type. 
Second,  experiments were made to test  the effect of the presence  of small 
numbers of the Thomas bacteria upon the protective action of Type II serum; 
tests being made against:  (a)  Type II bacteria alone;  (b) mixtures of Type II 
and Thomas bacteria in proportion of 10,000 to 1; (c) mixtures of Type II and 
Thomas bacteria in proportion of 100,000 to 1.  The results of these experiments 
were analogous  to the first ones;  and in this case (due to the higher degree of 
homologous protection of the Type II serum), the protection test served to detect 
the presence of Thomas (heterologous) bacteria in the Type II culture even when 
present in the proportion of 1 to 100,000 of the homologous organisms. 
DISCUSSION. 
The preceding experiments dealt with the immunological properties 
of the  Thomas  strain  of Pneumococcus which  is  related to  but  not 
identical with typical Type III strains.  In respect to the reactions in 
potent  anti-Type  III  immune horse serum,  the relationship between 
the Thomas strain and typical Type III strains is about the same as 
that evidenced in anti-Type II serum between typical  Type II strains 
and most of Avery's Subgroup II strains.  But, when the comparison is 
made in anti-Thomas immune serum, it is evident that the relationship 
of the Thomas strain to typical Type III pneumococcus is different, for 
the anti-Thomas immune serum (from most rabbits)  agglutinates and 928  pNEI.TMOCOCCI.  I 
protects against typical Type III, while none  of  the  anti-Subgroup 
H  immune sera were reactive against typical Type II  pneumococci. 
The production of sera reactive against typical Type III pneumococci 
by injection of the Thomas strain is particularly interesting in view 
of the rarity of obtaining an  effective  anti-Type III immunity re- 
sponse in rabbits by the injection of typical Type III pneumococci. 
From these results it  appears that antibodies reactive with  typical 
Type III pneumococci can be produced more readily when rabbits are 
immunized with  the  Thomas bacteria  than  when immunized with 
typical Type III bacteria themselves.  Whether the  antigen in the 
Thomas bacterial cell which is responsible for the antibody reactive 
with the Type III bacteria is the same as the corresponding antigen in 
the Type III bacterial cell is another question. 
The anti-Type III immune serum from different horses and the anti- 
Thomas serum from different rabbits,  usually contained antibodies 
reactive both with the Thomas bacteria and with the typical Type III 
bacteria.  It is particularly important that there was an entire lack 
of any regular relation between the relative anti-Thomas and anti- 
Type III potencies of the  different individual antisera.  The  pro- 
nounced variations in the relative potencies of individual antisera in 
respect to  antibodies reactive with  the  two  kinds of  pneumococci 
may represent differences in the relative proportion of two different 
anti-S antibodies in the antiserum from different individual animals. 
The  variation  in  the  anti-Type III potency of the  different  anti- 
Thomas sera is probably due to differences in the response of the indi- 
vidual rabbits to the particular Thomas antigen which gives rise to the 
anti-Type III antibody, for Tillett (3)  found marked  differences in 
the  individual anti-Type  III  responses of  rabbits  when  Type  III 
bacteria  themselves were  injected.  The  possible  variations  in  the 
antigenic character of the cultures (both of the Thomas and of the 
typical Type III strains) does not seem to be a likely explanation of the 
variations in the immune sera for we frequently obtained wide differ- 
ences in the relative anti-Type III potency in the anti-Thomas sera of 
different rabbits immunized at the same time with equal amounts of 
the same Thomas vaccine. 
The results of absorption experiments with both typical Type III 
antiserum and Thomas antiserum were the same as those usually ob- SUGG, GASPARI~ ]~LEMING~ AND  NEILL  929 
tained in similar tests with immunologicaUy related, but not identical 
bacteria.  That is, homologous absorption removed all of the antibodies 
from each serum, and heterologous absorption removed only the anti- 
bodies reactive with the strain used in absorption and failed to exhaust 
the serum of antibodies reactive with the strain used in immunization. 
The failure of reciprocal absorption together with the variations in the 
Anti-Thomas potency 
relative potencies  ratioof ~~----~ncy]  of  the  antiserum 
from different individual animals could be presented as presumptive 
evidence that two different anti-S antibodies are contained in TypeIII 
immune horse serum.  Although there is no evidence of complexity 
among the type-specific antigens of the "fixed" types of pneumococci, 
the same S substance united with slightly different protein constitu- 
ents  might  give  rise  to  related  but  slightly  different  type-specific 
antibodies. 
In his original paper on the Subgroup Type II pneumococd, Avery 
(I) pointed out that the serological relationship did not in itsdf indi- 
cate that the Subgroup Type  II and typical Type II strains were 
related by the lineage of common descent.  The later developments 
in knowledge (2)  of the antigenic constituents of the pneumococcus 
cell show more dearly that a serological relationship like that between 
the Thomas strain and typical Type III strains is not always a true 
index of phylogenetic relations]alp.  It is now well known that there 
are two sorts of antigen-antibody systems involved in the immunologi- 
cal reactions of pneumococci: the S-anti-S reactions of type specificity, 
and the P-anti-P reactions of species  specificity.  There is much evi- 
dence that the second of these reactions is the more likely to indicate 
phylogenetic  or  truly  biological  relationship.  Since  the  S-anti-S 
reactions separate into distinct "types" the pneumococci which mani- 
fest group relationship by P-anti-P reactions, it is important to recog- 
nize the possibility of biologically fortuitous likenesses in the chemical 
structure of some one of the cell constituents of phylogenetically un- 
related bacteria.  This possibility is well illustrated by the similarity 
between the S substance of Type II pneumococci and the S substance 
of some strains of Friedl~inder's bacillus (5).  The common sense of 
the biologist would preclude the assumption of a  doser phylogenetic 
relationship between Type II pneumococcus and  FriedlRnder's bacil- 930  PNET~OCOCCI.  I 
lus than between Type II pneumococcus and Type I  or III,  simply 
because  of  a  greater  chemical likeness  between  the  carbohydrates 
elaborated by the bacteria.  But, in point of fact, as far as the S-anti- 
S reactions are concerned, the serological relationship of the Thomas 
bacteria to the typical Type III bacteria is no more pronounced than 
that between Friedl~inder bacilli and Type II pneumococci; and hence, 
there is no real reason to believe that the Thomas strain  is  any more 
closely related, in a truly biological sense, to Type III than to any other 
virulent Pneumococcus. 
In  the absence of any evidence  of phylogenetic relationship,  the 
Thomas strain can  best be considered as a  Pneumococcus which, in 
addition to distinct immunological properties of its own, possesses a 
partial antigenic relationship to the typical Type III pneumococcus. 
The degree of type specificity manifested by Types I, II and III pneu- 
mococci is of a higher order than that usually obtained between the 
"types" contained in most groups of bacteria.  But, in view of  the 
wide range of immunological possibilities that are presented by Group 
IV pneumococci, one can expect to  find a  certain number of pneu- 
mococci that are related to but  not identical with one of the "fixed" 
types.  While there have been few, if any reports  of  pneumococci 
related to Type III it is quite possible that  the use of a more highly 
reactive Type III diagnostic antiserum would result in the detection 
of strains related to Type III which would be included within Group 
IV on the basis of typing tests with weak Type III antiserum.  This 
possibility  is  mentioned  because  of  our  own  experience  with  the 
Thomas  strain.  When  first  typed  in  our  laboratory,  it  was  con- 
sidered a Group IV strain and its Type III relationship was not recog- 
nized until  a  subsequent  typing test was made with a  more  potent 
Type III antiserum than that which we had been using for  routine 
typing. 
SUMMARy, 
The paper reports a study of a virulent, S-producing strain of Pneu- 
mococcus which is immunologically related to,  but not identical with 
typical strains of Type III pneumococcus.  In a potent anti-Type III 
serum, the relationship of this strain to typical Type III strains appears 
to be about the same as the relationship of Avery's Subgroup Type II SUGG~ GASPAI~I~ ]~L]E~KING,  AND NEILL  931 
strains  to  typical  Type II.  But  a  more pronounced distinction is 
evident in the antiserum produced by immunization with the strain 
related to Type III.  This antiserum contained antibodies specifically 
reactive with typical Type III bacteria as well as antibodies reactive 
with the homologous strain, while anti-Subgroup Type II immune sera 
are devoid of antibodies reactive with typical Type II pneumococci. 
The results of absorption experiments were the same as those usually 
obtained with  immunologically related,  but  not  identical  bacteria. 
The failure of reciprocal absorption and the marked variations in the 
relative potencies of the antiserum from different individual animals 
might be presented as presumptive evidence that two different anti- 
S antibodies are contained in Type III immune horse serum. 
The theoretical significance  of virulent pneumococci  which are related 
to but not identical with the "fixed" types, is discussed from the stand- 
point of their importance in the biological classification of the Pneu- 
mococcus group. 
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